Inventor
HORWITZ MARCUS A
US24 patents
⚠️ This page may combine multiple inventors who share the name “HORWITZ MARCUS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
18 patentsUS5108745AApr 28, 1992
Tuberculosis and legionellosis vaccines and methods for their production
UNIV CALIFORNIA67 citations96
US6054133AApr 25, 2000
Anti-microbial targeting for intracellular pathogens
UNIV CALIFORNIA18 citations91
US5721209AFeb 24, 1998
Iron chelator and inhibitor of iron-mediated oxidant injury
UNIV CALIFORNIA30 citations88
US6471967B1Oct 29, 2002
Recombinant intracellular pathogen vaccines and methods for use
UNIV CALIFORNIA14 citations82
US6924118B2Aug 2, 2005
Recombinant intracellular pathogen immunogenic compositions and methods for use
UNIV CALIFORNIA12 citations81
US6599510B1Jul 29, 2003
Abundant extracellular products and methods for their production and use
UNIV CALIFORNIA13 citations81
US7622107B2Nov 24, 2009
Recombinant intracellular pathogen immunogenic compositions and methods for use
UNIV CALIFORNIA6 citations71
US10010595B2Jul 3, 2018
Live recombinant booster vaccine against tuberculosis
UNIV CALIFORNIA4 citations70
US11045555B2Jun 29, 2021
Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles
UNIV CALIFORNIA5 citations67
US6761894B1Jul 13, 2004
Abundant extracellular products and methods for their production and use
UNIV CALIFORNIA4 citations62
US6752993B1Jun 22, 2004
Abundant extracellular product vaccines and methods for their production and use
UNIV CALIFORNIA3 citations62
US5994346ANov 30, 1999
Use of exochelins in the preservation of organs for transplant
UNIV CALIFORNIA3 citations61
US6818223B2Nov 16, 2004
Abundant extracellular products and methods for their production and use
UNIV CALIFORNIA2 citations60
US6013660AJan 11, 2000
Externally targeted prophylactic and chemotherapeutic method and agents
UNIV CALIFORNIA5 citations60
US11224647B2Jan 18, 2022
Safe potent single platform vaccine against Tier 1 select agents and other pathogens
UNIV CALIFORNIA1 citations59
US7002002B2Feb 21, 2006
Abundant extracellular products and methods for their production and use
UNIV CALIFORNIA0 citations49
US7300660B2Nov 27, 2007
Abundant extracellular products and methods for their production and use
UNIV CALIFORNIA1 citations44
US8383132B2Feb 26, 2013
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
UNIV CALIFORNIA1 citations42
HORWITZ MARCUS A
6 patentsUS8206700B2Jun 26, 2012
Methods and compositions for treating tularemia
HORWITZ MARCUS A16 citations78
US8124068B2Feb 28, 2012
Recombinant intracellular pathogen immunogenic compositions and methods of use
HORWITZ MARCUS A5 citations69
US8163294B2Apr 24, 2012
Growth regulatable recombinant BCG compositions
HORWITZ MARCUS A2 citations59
US8481024B2Jul 9, 2013
Vaccines against tularemia
HORWITZ MARCUS A3 citations57
US8287879B2Oct 16, 2012
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
HORWITZ MARCUS A1 citations49
US8932846B2Jan 13, 2015
Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins
HORWITZ MARCUS A0 citations48